Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) has a half-life of approximately five days, meaning it takes around five weeks for the medicine to clear your system after your last injection. Because doses are given once weekly, tirzepatide builds to a steady level in the blood within roughly four to five weeks of starting treatment. That pharmacokinetic pattern shapes everything from how you feel between doses to what happens if you stop — and it's worth understanding properly. As a Prescription-Only Medicine, Mounjaro requires a clinical assessment before a prescriber can decide whether it's right for you; the information below is educational, not personal medical advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Wednesday, your pen is still in the fridge from last Saturday, and you're wondering whether the medicine is still doing anything. The answer is almost certainly yes. With a half-life of roughly five days, the concentration of tirzepatide in your blood drops by about half every five days, so six or seven days after your last injection, a meaningful amount is still circulating. That's by design. It's why once-weekly dosing works at all.
For most people, this means a single missed dose by a day or two creates only a modest dip in active drug levels. The clinical picture is more gradual than with shorter-acting medicines. That said, if you're uncertain what to do after a missed injection, the right move is to consult the Patient Information Leaflet and speak to your prescriber rather than doubling up, dosing decisions belong with the clinical team, not a calculator.
If you want a fuller picture of how tirzepatide moves through the body, our page on how long tirzepatide lasts in your system goes into the pharmacokinetics in more detail. The NHS tirzepatide medicines page also covers what to do if you miss a dose.
One thing a lot of people find frustrating in the first fortnight is that the appetite-suppressing effect feels unpredictable. That's not imaginary. Tirzepatide accumulates with each weekly injection, and it takes four to five doses before blood levels plateau at what pharmacologists call steady state. Before that point, concentrations are still climbing after each injection and falling more between them.
This is also why the 2.5mg starting dose is structured the way it is. Its primary job is to let your digestive system adjust, nausea and other gastrointestinal effects are most common during dose increases, and starting low gives your body time to settle. The stronger appetite effects typically become more consistent once steady state is reached and dose titration progresses. If you're curious how quickly Mounjaro begins to produce noticeable changes, the page on how long Mounjaro takes to work covers that week-by-week picture. And if you're wondering how gastric emptying interacts with what you eat, there's useful context on how long food takes to digest on Mounjaro.
Clinical trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed that meaningful weight reduction was already measurable by week twelve at the therapeutic doses, with the greatest effects continuing to accumulate through to week seventy-two.
This is the question our prescribers hear most often from people considering a treatment break. Because tirzepatide's half-life is around five days, it takes approximately five half-lives (roughly twenty-five days, or about three and a half weeks) to fall to levels that are no longer pharmacologically significant. Full clearance from the body takes a little longer still.
In practical terms, the appetite-suppressing effects of Mounjaro tend to ease gradually over the weeks following the last injection rather than switching off overnight. Hunger typically returns in a stepwise fashion as concentrations fall. Weight regain is a well-documented pattern after stopping GLP-1 and GIP/GLP-1 medicines; the SURMOUNT-1 trial data showed participants who discontinued regained a substantial proportion of the weight lost. This is consistent with the understanding that obesity is a chronic condition, not one that a fixed course of medicine resolves permanently.
For anyone considering private treatment or exploring what comes after a course ends, the Mounjaro treatment overview covers the broader picture, and our team at about us explains the clinical infrastructure behind every prescription. If cost is a factor in your thinking, the Mounjaro price page sets out what's included in private treatment clearly.
The long half-life has a few practical knock-on effects worth knowing about before you make any changes to other medicines or treatments. For women using oral contraceptives, UK guidance advises adding a barrier method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying and may reduce how reliably an oral pill is absorbed. NHS England also notes that transdermal HRT (patches or gels rather than tablets) is worth discussing with your doctor during Mounjaro treatment for the same reason.
If you're due any surgical procedure, you should tell your anaesthetist and surgical team that you are taking tirzepatide; the slower gastric emptying it causes is relevant to anaesthetic safety. These aren't reasons to avoid treatment, but they are reasons why a prescriber who knows your full medical picture needs to be part of any timing decision.
If you'd like to understand how the medicine's staying power compares across different dose levels, the page on how long Mounjaro stays in your system breaks that down. Our frequently asked questions page covers many of the practical queries that come up after treatment starts. When you're ready to discuss your own situation with a clinician, checking your eligibility is the natural next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.